Comprehensive analyses reveal the promising value of gasdermins as prognostic biomarkers and immunotherapeutic targets in head and neck squamous cell carcinoma

Comprehensive analyses reveal the promising value of gasdermins as prognostic biomarkers and immunotherapeutic targets in head and neck squamous cell carcinoma

Background: In several studies of head and neck squamous cell carcinoma (HNSC), the regulation of tumorigenesis and therapeutic sensitivity by pyroptosis has been observed. However, a systematic analysis of gasdermin family members (GSDMs, including GSDMA/B/C/D/E and PJVK), which are deterministic e...

Full description

Saved in:

Bibliographic Details
Main Authors:	Huageng Huang, Jingjing Ge, Shunzhen Lu, Xinyi Deng, Ying Tian, He Huang, Zhao Wang, Yuyi Yao, Huangming Hong, Tongyu Lin
Format:	Article
Language:	English
Published:	Elsevier 2025-01-01
Series:	Heliyon
Subjects:	Antitumor immunity Gasdermin Head and neck squamous cell carcinoma Prognosis Pyroptosis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024172441
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Understanding the mechanisms of hypoxia-induced tissue damage in fish: The role of GasderminEa/b in Larimichthys crocea
by: Lin Wang, et al.
Published: (2025-01-01)

The serum levels of gasdermin D in uremic patients and its relationship with the prognosis: a prospective observational cohort study
by: XiaPing Zhang, et al.
Published: (2024-12-01)

Exploiting gasdermin-mediated pyroptosis for enhanced antimicrobial activity of phage endolysin against Pseudomonas aeruginosa
by: Dorota Kuc-Ciepluch, et al.
Published: (2025-01-01)

Prosaposin – A plausible biomarker in head and neck squamous cell carcinoma
by: Avradeep Datta, et al.
Published: (2024-03-01)

Immunosuppression and Outcomes in Patients with Cutaneous Squamous Cell Carcinoma of the Head and Neck
by: Doriana Iancu, et al.
Published: (2025-01-01)

Panoptosis – new frontier in research in head neck cancer
by: Shrikant B. Mali
Published: (2024-06-01)

Cetuximab Plus Methotrexate in Recurrent and/or Metastatic Head-and-Neck Squamous Cell Carcinoma
by: Wen-Chen Tang, et al.
Published: (2023-07-01)

Understanding the tumor microenvironment for personalized immunotherapy in early-onset head and neck squamous cell carcinoma
by: Yidan Shan, et al.
Published: (2025-01-01)

Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
by: Toyaja Jadhav, et al.
Published: (2023-07-01)

Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review
by: Joshua Lubov, et al.
Published: (2021-09-01)

Expression and prognosis of cellular senescence genes in head and neck squamous cell carcinoma
by: Chen Feng, et al.
Published: (2025-01-01)

Recent advances of photodiagnosis and treatment for head and neck squamous cell carcinoma
by: Yining Zhang, et al.
Published: (2025-02-01)

Clinical Benefits of Metronomic Chemotherapy in Platinum-Refractory, Recurrent, and Metastatic Head and Neck Squamous Cell Carcinoma
by: Amira Elwan, et al.
Published: (2025-01-01)

Targeting ferroptosis for improved radiotherapy outcomes in HPV‐negative head and neck squamous cell carcinoma
by: Joo Kyung Noh, et al.
Published: (2025-02-01)

Individualized treatment recommendations for patients with locally advanced head and neck squamous cell carcinoma utilizing deep learning
by: Linmei Zhang, et al.
Published: (2025-01-01)

Neoadjuvant chemoimmunotherapy for locally advanced squamous cell carcinoma of the head and neck: Systematic review and meta-analysis
by: Xiayi Zhu, et al.
Published: (2025-02-01)

Response to induction chemotherapy as a prognostic indicator in locally advanced head and neck squamous cell carcinoma
by: Francesca Huwyler, et al.
Published: (2024-12-01)

Correlation between Ki-67 labeling index and mitotic index in Head and neck squamous cell carcinoma
by: Das C. K Deepa, et al.
Published: (2024-12-01)

A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets
by: Lin Li, et al.
Published: (2025-01-01)

Promising Response with PI3K Inhibitor for a Patient with Heavily Pretreated PIK3CA Mutation Head-and-Neck Cancer
by: Ming-Jing Lee, et al.
Published: (2023-04-01)

Disulfidptosis-related gene SLC3A2: a novel prognostic biomarker in nasopharyngeal carcinoma and head and neck squamous cell carcinoma
by: Xinyi Zhang, et al.
Published: (2025-01-01)

MicroRNA-129-3p Suppresses Tumor Progression and Chemoradioresistance in Head and Neck Squamous Cell Carcinoma
by: Tae Mi Yoon, et al.
Published: (2025-01-01)

Meta-analysis of the effect of non-pharmacological interventions on the development of dysgeusia in patients undergoing radiotherapy for head and neck squamous cell carcinoma
by: Yuyang Li, et al.
Published: (2025-01-01)

Nomogram-derived immune-inflammation-nutrition score could act as a novel prognostic indicator for patients with head and neck squamous cell carcinoma
by: Wen-Yan Wang, et al.
Published: (2025-01-01)

Evaluating H2BC9 as a potential diagnostic and prognostic biomarker in head and neck squamous cell carcinoma
by: Lanhua Wu, et al.
Published: (2025-01-01)

Understanding the role of nerves in head and neck cancers - a review
by: Krzysztof Rutkowski, et al.
Published: (2025-01-01)

Exploring salivary gene expression clusters: A bioinformatics approach for advanced diagnosis and prognosis in head and neck squamous cell carcinoma
by: Rajesh Parsanathan, et al.
Published: (2024-06-01)

Identification of novel therapeutic targets for head and neck squamous cell carcinoma through bioinformatics analysis
by: Eun-jeong Jeong, et al.
Published: (2024-12-01)

Efficacy and safety of immunotherapy for head and neck squamous cell carcinoma: a meta-analysis of randomized clinical trials
by: Cailing Jiang, et al.
Published: (2025-01-01)

Donor site scar preference in head and neck free flap reconstruction: The patient point of view
by: Andrea Iandelli, et al.
Published: (2024-06-01)

The N‐terminal domain of gasdermin D induces liver fibrosis by reprogrammed lipid metabolism
by: Xue Wang, et al.
Published: (2025-01-01)

Microbial signatures in head and neck squamous cell carcinoma: an in silico study
by: Loganathan KAVITHA, et al.
Published: (2025-02-01)

Kruppel-family zinc finger proteins as emerging epigenetic biomarkers in head and neck squamous cell carcinoma
by: Patrick Pearson, et al.
Published: (2023-05-01)

Late-onset and relapsed cytokine release syndrome after nivolumab treatment in a patient with head and neck squamous cell carcinoma: a case report
by: Tomoyuki Otsuka, et al.
Published: (2025-02-01)

CircCCT2/miR-146a-5p/IRAK1 axis promotes the development of head and neck squamous cell carcinoma
by: Long He, et al.
Published: (2025-01-01)

Depth-dependent PD-L1 sampling of head and neck squamous cell carcinoma (HNSCC) – implications for PD-1/PD-L1 checkpoint inhibitor immunotherapy
by: Madhusudan Roy, et al.
Published: (2024-03-01)

SMAC-armed oncolytic virotherapy enhances the anticancer activity of PD1 blockade by modulating PANoptosis
by: Fanghui Chen, et al.
Published: (2025-01-01)

The volatilome – investigation of volatile organic metabolites (VOM) as potential tumor markers in patients with head and neck squamous cell carcinoma (HNSCC)
by: Philipp Opitz, et al.
Published: (2018-07-01)

Prognostic Factors of Liposarcoma in Head and Neck
by: Shuo DING, et al.
Published: (2025-01-01)

RNA-binding protein HuR reprograms immune T cells and promotes oral squamous cell carcinoma
by: Mrinmoyee Majumder, et al.
Published: (2024-06-01)